CVE-2024-30114

CVE-2024-30114 is a low-severity vulnerability in Hcltech Hcl Leap with a CVSS 3.x base score of 3.7. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Description

Insufficient sanitization in HCL Leap allows client-side script injection in the authoring environment.

Frequently asked questions

What is CVE-2024-30114?
Insufficient sanitization in HCL Leap allows client-side script injection in the authoring environment.
How severe is CVE-2024-30114?
CVE-2024-30114 has a CVSS 3.x base score of 3.7, rated low severity. It is exploitable over network with high attack complexity, requires low privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2024-30114 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (9th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2024-30114?
CVE-2024-30114 affects Hcltech Hcl Leap. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2024-30114?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2024-30114 have an EU (EUVD) identifier?
Yes. CVE-2024-30114 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-28050.
When was CVE-2024-30114 published?
CVE-2024-30114 was published on 2025-04-24 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Hcltech Hcl Leap

All CVEs affecting Hcltech Hcl Leap →

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →